KEGG Orthology (KO) - Rattus norvegicus (rat)

[ Brite menu | Organism menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level 

     KO
 Metabolism
 
 Genetic Information Processing
 
 Environmental Information Processing
 
 Cellular Processes
 
 Organismal Systems
 
   Immune system
     04640 Hematopoietic cell lineage [PATH:rno04640]
     04610 Complement and coagulation cascades [PATH:rno04610]
       306761 F12; coagulation factor XII (Hageman factor) 
       25048 Klkb1; kallikrein B, plasma 1 
       24903 Kng1; kininogen 1
       25087 Kng2; kininogen 2
       81509 Bdkrb1; bradykinin receptor B1
       25245 Bdkrb2; bradykinin receptor B2
       290757 F11; coagulation factor XI 
       24946 F9; coagulation factor IX 
       302470 F8; coagulation factor VIII, procoagulant component
       116669 Vwf; von Willebrand factor
       25584 F3; coagulation factor III (thromboplastin, tissue factor)
       260320 F7; coagulation factor VII (serum prothrombin conversion accelerator) 
       29243 F10; coagulation factor X 
       304929 F5; coagulation factor V (proaccelerin, labile factor)
       29251 F2; coagulation factor II 
       361969 Fga; fibrinogen alpha chain
       24366 Fgb; fibrinogen beta chain
       24367 Fgg; fibrinogen gamma chain
       60327 F13a1; coagulation factor XIII, A1 polypeptide 
       289055 F13b; coagulation factor XIII, B polypeptide 
       83580 Thbd; thrombomodulin
       25268 Proc; protein C 
       81750 Pros1; protein S (alpha)
       25692 Plat; plasminogen activator, tissue 
       25619 Plau; plasminogen activator, urokinase 
       85253 Plg; plasminogen 
       29436 Tfpi; tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
       79224 Serpind1; serpin peptidase inhibitor, clade D (heparin cofactor), member 1
       113936 Cpb2; carboxypeptidase B2 (plasma) 
       24617 Serpine1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
       287527 Serpinf2; serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
       304917 Serpinc1; serpin peptidase inhibitor, clade C (antithrombin), member 1
       65051 Serpina5; serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
       24153 A2m; alpha-2-macroglobulin
       100911545 alpha-2-macroglobulin-like
       24648 Serpina1; serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
       25439 F2r; coagulation factor II (thrombin) receptor
       50692 Plaur; plasminogen activator, urokinase receptor
       298566 C1qa; complement component 1, q subcomponent, A chain
       29687 C1qb; complement component 1, q subcomponent, B chain
       362634 C1qc; complement component 1, q subcomponent, C chain
       312705 C1r; complement component 1, r subcomponent 
       192262 C1s; complement component 1, s subcomponent 
       24231 C2; complement component 2 
       24233 C4a; complement component 4A (Rodgers blood group)
       24232 C3; complement component 3 
       294257 Cfb; complement factor B 
       54249 Cfd; complement factor D (adipsin) 
       24548 Mbl1; mannose-binding lectin (protein A) 1
       64668 Mbl2; mannose-binding lectin (protein C) 2
       100911854 mannose-binding protein C-like
       64023 Masp1; mannan-binding lectin serine peptidase 1
       64459 Masp2; mannan-binding lectin serine peptidase 2 
       362119 C5; complement component 5
       24237 C6; complement component 6
       117517 C7; complement component 7
       298288 C8a; complement component 8, alpha polypeptide
       313421 C8b; complement component 8, beta polypeptide
       296545 C8g; complement component 8, gamma polypeptide
       117512 C9; complement component 9
       295703 Serping1; serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
       24235 C4bpa; complement component 4 binding protein, alpha
       24236 C4bpb; complement component 4 binding protein, beta
       155012 Cfh; complement factor H 
       79126 Cfi; complement factor I 
       54243 Cr1l; complement component (3b/4b) receptor 1-like
       64036 Cd55; Cd55 molecule
       29333 Cd46; CD46 molecule, complement regulatory protein
       25407 Cd59; CD59 molecule, complement regulatory protein
       84007 C3ar1; complement component 3a receptor 1
       113959 C5ar1; complement component 5a receptor 1
       289395 Cr2; complement component (3d/Epstein Barr virus) receptor 2
K01328 F12; coagulation factor XII (Hageman factor) [EC:3.4.21.38]
K01324 KLKB1; plasma kallikrein [EC:3.4.21.34]
K03898 KNG; kininogen
K03898 KNG; kininogen
K03915 BDKRB1; bradykinin receptor B1
K03916 BDKRB2; bradykinin receptor B2
K01323 F11; coagulation factor XI [EC:3.4.21.27]
K01321 F9; coagulation factor IX (Christmas factor) [EC:3.4.21.22]
K03899 F8; coagulation factor VIII
K03900 VWF; von Willebrand factor
K03901 F3; coagulation factor III (tissue factor)
K01320 F7; coagulation factor VII [EC:3.4.21.21]
K01314 F10; coagulation factor X [EC:3.4.21.6]
K03902 F5; coagulation factor V (labile factor)
K01313 F2; coagulation factor II (thrombin) [EC:3.4.21.5]
K03903 FGA; fibrinogen alpha chain
K03904 FGB; fibrinogen beta chain
K03905 FGG; fibrinogen gamma chain
K03917 F13A1; coagulation factor XIII A1 polypeptide [EC:2.3.2.13]
K03906 F13B; coagulation factor XIII B polypeptide
K03907 THBD; thrombomodulin
K01344 PROC; protein C (activated) [EC:3.4.21.69]
K03908 PROS1; protein S
K01343 PLAT; tissue plasminogen activator [EC:3.4.21.68]
K01348 PLAU; urokinase plasminogen activator [EC:3.4.21.73]
K01315 PLG; plasminogen [EC:3.4.21.7]
K03909 TFPI; tissue factor pathway inhibitor
K03912 SERPIND1; heparin cofactor II
K01300 CPB2; carboxypeptidase B2 [EC:3.4.17.20]
K03982 SERPINE1; plasminogen activator inhibitor-1
K03983 SERPINF2; alpha-2-antiplasmin
K03911 SERPINC1; antithrombin III
K03913 SERPINA5; protein C inhibitor
K03910 A2M; alpha-2-macroglobulin
K03910 A2M; alpha-2-macroglobulin
K03984 SERPINA1; alpha-1-antitrypsin
K03914 F2R; coagulation factor II (thrombin) receptor
K03985 PLAUR; plasminogen activator, urokinase receptor
K03986 C1QA; complement C1q subcomponent subunit A
K03987 C1QB; complement C1q subcomponent subunit B
K03988 C1QG; complement C1q subcomponent subunit C
K01330 C1R; complement component 1, r subcomponent [EC:3.4.21.41]
K01331 C1S; complement component 1, s subcomponent [EC:3.4.21.42]
K01332 C2; complement component 2 [EC:3.4.21.43]
K03989 C4; complement component 4
K03990 C3; complement component 3
K01335 CFB; component factor B [EC:3.4.21.47]
K01334 CFD; component factor D [EC:3.4.21.46]
K03991 MBL; mannose-binding lectin
K03991 MBL; mannose-binding lectin
K03991 MBL; mannose-binding lectin
K03992 MASP1; mannan-binding lectin serine protease 1 [EC:3.4.21.-]
K03993 MASP2; mannan-binding lectin serine protease 2 [EC:3.4.21.104]
K03994 C5; complement component 5
K03995 C6; complement component 6
K03996 C7; complement component 7
K03997 C8A; complement component 8 subunit alpha
K03998 C8B; complement component 8 subunit beta
K03999 C8G; complement component 8 subunit gamma
K04000 C9; complement component 9
K04001 SERPING1; C1 inhibitor
K04002 C4BPA; complement component 4 binding protein, alpha
K04003 C4BPB; complement component 4 binding protein, beta
K04004 HF1; complement factor H
K01333 CFI; complement factor I [EC:3.4.21.45]
K04005 CRRY; complement receptor related protein
K04006 DAF; decay accelerating factor
K04007 CD46; membrane cofactor protein
K04008 CD59; CD59 antigen
K04009 C3AR1; C3a anaphylatoxin chemotactic receptor
K04010 C5AR1; C5a anaphylatoxin chemotactic receptor
K04012 CR2; complement receptor type 2
     04611 Platelet activation [PATH:rno04611]
     04620 Toll-like receptor signaling pathway [PATH:rno04620]
     04621 NOD-like receptor signaling pathway [PATH:rno04621]
     04622 RIG-I-like receptor signaling pathway [PATH:rno04622]
     04623 Cytosolic DNA-sensing pathway [PATH:rno04623]
     04650 Natural killer cell mediated cytotoxicity [PATH:rno04650]
     04612 Antigen processing and presentation [PATH:rno04612]
     04660 T cell receptor signaling pathway [PATH:rno04660]
     04662 B cell receptor signaling pathway [PATH:rno04662]
     04664 Fc epsilon RI signaling pathway [PATH:rno04664]
     04666 Fc gamma R-mediated phagocytosis [PATH:rno04666]
     04670 Leukocyte transendothelial migration [PATH:rno04670]
     04672 Intestinal immune network for IgA production [PATH:rno04672]
     04062 Chemokine signaling pathway [PATH:rno04062]
 
   Endocrine system
 
   Circulatory system
 
   Digestive system
 
   Excretory system
 
   Nervous system
 
   Sensory system
 
   Development
 
   Environmental adaptation
 
 Human Diseases

[ BRITE | KEGG2 | KEGG ]
Last updated: September 16, 2014